Chronic sequelae of E. coli O157: Systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae

Foodborne Pathogens and Disease

Volumn 11, Issue 2, 2014, Pages 79-95

  Keithlin, Jessica ^a,b   Sargeant, Jan ^a,b   Thomas, M Kate ^c   Fazil, Aamir ^c  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM IDENTIFICATION; DATA EXTRACTION; ESCHERICHIA COLI O157; FOOD SAFETY; GUILLAIN BARRE SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; SCREENING; SELF REPORT; SYSTEMATIC REVIEW;

ARTHRITIS, REACTIVE; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IRRITABLE BOWEL SYNDROME; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 84893109486     PISSN: 15353141     EISSN: 15567125     Source Type: Journal    
DOI: 10.1089/fpd.2013.1572     Document Type: Review

References (105)

1. Afza M, Hawker J, Thurston H, et al. An outbreak of Escherichia coli O157 gastroenteritis in a care home for the elderly. Epidemiol Infect 2006;134:1276-1281
2. Al-Jader L, Salmon RL, Walker AM, et al. Outbreak of Escherichia coli O157 in a nursery: Lessons for prevention. Arch Dis Child 1999;81:60-63
3. Ammon A. Surveillance of enterohaemorrhagic E. coli (EHEC) infections and haemolytic uraemic syndrome (HUS) in Europe. Euro Surveill 1997;2:91-96
4. Bell BP, Goldoft M, Griffin PM, et al. A multistate outbreak of Escherichia coli O157:H7-Associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: The Washington experience. J Am Med Assoc 1994;272:1349-1353
5. Bell BPB, Griffin PMP, Lozano PP, et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 1997;100:E12-E12
6. Belongia EA, Osterholm MT, Soler JT, et al. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. J Am Med Assoc 1993;269:883-888
7. Besser RE, Lett SM, Weber JT, et al. An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider. J Am Med Assoc 1993; 269:2217-2220
8. Blackwell CC, Dundas S, James VS, et al. Blood group and susceptibility to disease caused by Escherichia coli O157. J Infect Dis 2002;185:393-396
9. Borenstein M, Hedges L, Rothstein H. Introduction to Meta-Analysis. West Sussex, UK: John Wiley & Sons, 2009
10. Buteau C, Proulx F, Chaibou M, et al. Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome. Pediatr Infect Dis J 2000;19:642-647
11. [CDC] Centers for Disease Control and Prevention. Outbreak of Escherichia coli O157:H7 infection-Georgia and Tennessee, June 1995. Morb Mortal Wkly Rep 1996a;45:249-251
12. CDC. Outbreak of Escherichia coli O157:H7 infections associated with drinking unpasteurized commercial apple juice: British Columbia, California, Colorado, and Washington, October 1996. Mortal Wkly Rep 1996b;45:975
13. CDC. Multistate outbreak of Escherichia coli O157:H7 infections associated with eating ground beef: United States, June-July 2002. Morb Mortal Wkly Rep 2002;51:637-639
14. CDC. Outbreaks of Escherichia coli O157:H7 associated with petting zoos: North Carolina, Florida, and Arizona, 2004 and 2005. Morb Mortal Wkly Rep 2005;54:1277-1280
15. CDC. Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach-United States, September 2006. Morb Mortal Wkly Rep 2006;55:1045-1046
16. Cimolai N, Basalyga S, Mah DG, et al. A continuing assessment of risk factors for the development of Escherichia coli O157:H7-Associated hemolytic uremic syndrome. Clin Nephrol 1994;42:85-89
17. Cornick NA, Jelacic S, Ciol MA, et al. Escherichia coli O157:H7 infections: Discordance between filterable fecal shiga toxin and disease outcome. J Infect Dis 2002;186:57-63
18. Davies M, Engel J, Griffin D, et al. Outbreaks of Escherichia coli O157:H7 associated with petting zoos-North Carolina, Florida, and Arizona, 2004 and 2005. JAMA 2006;295:378-380
19. Davis M, Osaki C, Gordon D. Update: Multistate outbreak of Escherichia coli O157:H7 infections from hamburgers-Western United States, 1992-1993. Morb Mortal Weekly Rep 1993; 42:258-263
20. Diallo MO, Bradley KK, Crutcher JM, et al. An outbreak of Escherichia coli O157:H7 infection linked to unpasteurized apple cider in Oklahoma, 1999. Food Prot Trends 2011;31:88-92
21. Duncan L, Mai V, Carter A, et al. Outbreak of gastrointestinal disease-Ontario. Can Dis Weekly Rep 1987;13:5-8
22. Dundas S, Todd WT, Stewart AI, et al. The central Scotland Escherichia coli O157:H7 outbreak: Risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 2001;33:923-931
23. Egger M, Davey Smith G, Altmand DG. Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd ed. London: Brit Med J, 2001
24. Espie E, Vaillant V, Mariani-Kurkdjian P, et al. Escherichia coli O157 outbreak associated with fresh unpasteurized goats' cheese. Epidemiol Infect 2006;134:143-146
25. Ethelberg S, Olsen KE, Scheutz F, et al. Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis 2004; 10:842-847
26. Farquhar D. E. coli, antibiotics and hemolytic-uremic syndrome in children. CMAJ 2000;163:438
27. Fukushima H, Hashizume T, Morita Y, et al. Clinical experiences in Sakai city hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai city, 1996. Pediatr Int 1999;41:213-217
28. Gammie AJ, Mortimer PR, Hatch L, et al. Outbreak of verocytotoxin- producing Escherichia coli O157 associated with cooked ham from a single source. PHLS Microbiol Digest 1996;13:142-145
29. Garg AX, Clark WF, Salvadori M, et al. Absence of renal sequelae after childhood Escherichia coli O157:H7 gastroenteritis. Kidney Int 2006a;70:807-812
30. Garg AX, Salvadori M, Moist LM, et al. Renal prognosis of toxigenic Escherichia coli infection. Kidney Int Suppl 2009;112: S38-S41
31. Garg AX, Pope JE, Thiessen-Philbrook H, et al. Arthritis risk after acute bacterial gastroenteritis. Rheumatology 2008a;47:200-204
32. Garg AX, Macnab J, Clark W, et al. Long-Term health sequelae following E. coli and campylobacter contamination of municipal water: Population sampling and assessing non-participation biases. Can J Public Health 2005;96:125-130
33. Garg AX, Suri RS, Barrowman N, et al. Long-Term renal prognosis of diarrhea-Associated hemolytic uremic syndrome: A systematic review, meta-Analysis, and meta-regression. J Am Med Assoc 2003;290:1360-1370
34. Garg AX, Marshall J, Salvadori M, et al. A gradient of acute gastroenteritis was characterized, to assess risk of long-Term health sequelae after drinking bacterial-contaminated water. J Clin Epidemiol 2006b;59:421-428
35. Garg AX, Salvadori M, Okell JM, et al. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: An update. Am J Kidney Dis 2008b;51:435-444
36. Goode B, O'Reilly C, Dunn J, et al. Outbreak of Escherichia coli O157. Arch Pediatr Adolesc Med 2009;163:42-48
37. Gould LH, Demma L, Jones TF, et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 2009;49:1480-1485
38. Gouveia S, Proctor ME, Lee MS, et al. Genomic comparisons and shiga toxin production among Escherichia coli O157:H7 isolates from a day care centre outbreak and sporadic cases in southeastern Wisconsin. J Clin Microbiol 1998;36:727-733
39. Gransden WR, Damm MA, Anderson JD, et al. Further evidence associating hemolytic uremic syndrome with infection by verotoxin-producing Escherichia coli O157:H7. J Infect Dis 1986;154:522-524
40. Griffin PM, Ostroff SM, Tauxe RV, et al. Illnesses associated with Escherichia coli O157:H7 infections. Ann Intern Med 1988; 109:705-712
41. Guh A, Quyen Phan, Nelson R, et al. Outbreak of Escherichia coli O157 associated with raw milk, Connecticut, 2008. Clin Infect Dis 2010;51:1411-1417
42. Hamano S, Nakanishi Y, Nara T, et al. Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paediatr 1993;82:454-458
43. Havelaar AH, Haagsma JA, Mangen MJ, et al. Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol 2012;156:231-238
44. [HPA] Health Protection Agency. European collaboration identifies an outbreak of Escherichia coli O157 infection in visitors to Fuerteventura, Canary Islands 1997. CDR Weekly 1997a; 7:127
45. [HPA]. Escherichia coli O157 outbreak in Lincolnshire 1997. CDR Weekly 1997b;7:101
46. Hedican EB, Medus C, Besser JM, et al. Characteristics of O157 versus non-O157 shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. Clin Infect Dis 2009;49:358-364
47. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-1558
48. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011;5.1.0. http://handbook .cochrane.org/, accessed December 2011
49. Honda T. Factors influencing the development of hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli infection: From a questionnaire survey to in vitro experiment. Pediatr Int 1999;41:209-212
50. Ikeda K, Ida O, Kimoto K, et al. Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clin Nephrol 1999;52:357-362
51. Ikeda K, Ida O, Kimoto K, et al. Predictors for the development of haemolytic uraemic syndrome with Escherichia coli O157:H7 infections: With focus on the day of illness. Epidemiol Infect 2000;124:343-349
52. Ishikawa N, Kamitsuji H, Murakami T, et al. Plasma levels of granulocyte elastase-Alpha1-proteinase inhibitor complex in children with hemolytic uremic syndrome caused by verotoxin-producing Escherichia coli. Pediatr Int 2000;42: 637-641
53. Jelacic S, Wobbe CL, Boster DR, et al. ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections. J Infect Dis 2002; 185:214-219
54. Karch H, Huppertz HI, Bockemuehl J, et al. Shiga toxin-producing Escherichia coli infections in Germany. J Food Prot 1997;60:1454-1457
55. Karmali MA. Infection by shiga toxin-producing Escherichia coli: An overview. Mol Biotechnol 2004;26:117-122
56. Karmali MA, Gannon V, Sargeant JM. Verocytotoxin-producing Escherichia coli (VTEC). Vet Microbiol 2010;140:360-370
57. Karmali MA, Petric M, Lim C, et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985;151: 775-782
58. Karmali MA, Arbus GS, Ish-Shalom N, et al. A family outbreak of hemolytic-uremic syndrome associated with verotoxinproducing Escherichia coli serotype O157:H7. Pediatr Nephrol 1988;2:409-414
59. Kawano K, Okada M, Haga T, et al. Relationship between pathogenicity for humans and stx genotype in shiga toxinproducing Escherichia coli serotype O157. Eur J Clin Microbiol Infect Dis 2008;27:227-232
60. King LA, Mailles A, Mariani-Kurkdjian P, et al. Communitywide outbreak of Escherichia coli O157:H7 associated with consumption of frozen beef burgers. Epidemiol Infect 2009; 137:889-896
61. Kitajima H, Ida S, Fujimura M. Daily bowel movements and Escherichia coli O157 infection. Arch Dis Child 2002;87: 335-336
62. Lerman YY, Cohen DD, Gluck AA, et al. A cluster of cases of Escherichia coli O157 infection in a day-care center in a communal settlement (kibbutz) in Israel. J Clin Microbiol 1992; 30:520-521
63. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-Analysis of studies that evaluation health care interventions. BMJ 2009;6:1-28
64. Liptakova A, Siegfried L, Rosocha J, et al. A family outbreak of haemolytic uraemic syndrome and haemorrhagic colitis caused by verocytotoxigenic Escherichia coli O157 from unpasteurised cow's milk in Slovakia. Clin Microbiol Infect 2004;10:576-578
65. Ludwig K, Ruder H, Bitzan M, et al. Outbreak of Escherichia coli O157:H7 infection in a large family. Eur J Clin Microbiol Infect Dis 1997;16:238-241
66. Melton-Celsa A, Mohawk K, Teel L, O'Brien A. Pathogenesis of Shiga-Toxin producing Escherichia coli. Curr Top Microbiol Immunol 2012;357:67-103
67. MacDonald IA, Gould IM, Curnow J. Epidemiology of infection due to Escherichia coli O157: A 3-year prospective study. Epidemiol Infect 1996;116:279-284
68. MacDonald KL, O'Leary MJ, Cohen ML. Escherichia coli O157:H7, an emerging gastrointestinal pathogen: Results of a one-year, prospective, population-based study. J Am Med Assoc 1988;259:3567-3570
69. McCarthy TA, Barrett NL, Hadler JL, et al. Hemolytic-uremic syndrome and Escherichia coli O121 at a lake in Connecticut, 1999. Pediatrics 2001;108:991-992
70. McDonnell RJ, Rampling A, Crook S, et al. An outbreak of vero cytotoxin producing Escherichia coli O157 infection associated with takeaway sandwiches. CDR Rev 1997;7: R201-R205
71. Milne LM, Plom A, Strudley I, et al. Escherichia coli O157 incident associated with a farm open to members of the public. Commun Dis Public Health 1999;2:22-26
72. Murray KF, Patterson K. Escherichia coli O157:H7-induced hemolytic-uremic syndrome: Histopathologic changes in the colon over time. Pediatr Dev Pathol 2000;3:232-239
73. O'Donnell JM, Thornton L, McNamara EB, et al. Outbreak of vero cytotoxin-producing Escherichia coli O157 in a child day care facility. Commun Dis Public Health 2002;5:54-58
74. Olsen SJ, Miller G, Breuer T, et al. A waterborne outbreak of Escherichia coli O157:H7 infections and hemolytic uremic syndrome: Implications for rural water systems. Emerg Infect Diseases 2002;8:370-375
75. Orr P, Lorencz B, Brown R, et al. An outbreak of diarrhea due to verotoxin-producing Escherichia coli in the Canadian northwest territories. Scand J Infect Dis 1994;26:675-684
76. Ostroff SM, Griffin PM, Tauxe RV. A statewide outbreak of Escherichia coli O157:H7 infections in Washington state. Am J Epidemiol 1990;132:239-247
77. Pai CH, Ahmed N, Lior H, et al. Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: A twoyear prospective study. J Infect Dis 1988;157:1054-1057
78. Palermo MS, Exeni RA, Fernández GC. Hemolytic uremic syndrome: Pathogenesis and update of interventions. Expert Rev Anti Infect Ther 2009;7:697-707
79. Payne CJ, Petrovic M, Roberts RJ, et al. Vero cytotoxin-producing Escherichia coli O157 gastroenteritis in farm visitors, North Wales. Emerg Infect Dis 2003;9:526-530
80. Pebody RG, Furtado C, Rojas A, et al. An international outbreak of vero cytotoxin-producing Escherichia coli O157 infection amongst tourists; a challenge for the European infectious disease surveillance network. Epidemiol Infect 1999;123:217-223
81. Pierard D, Stevens D, Moriau L, et al. Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples. Clin Microbiol Infect 1997;3:531-540
82. Pollock KGJ, Locking ME, Beattie TJ, et al. Sorbitol-fermenting Escherichia coli O157, Scotland. Emerg Infec Dis 2010;16:881-882
83. Public Health Agency of Canada. Population health impact of disease in canada: Canadian summary measures. Available at: Http://www.phac-Aspc.gc.ca/phi- isp/summary-measures-eng .php. Updated 2005, accessed August 24, 2012
84. Raffaelli RM, Paladini M, Hanson H, et al. Child care-Associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome. Pediatr Infect Dis J 2007;26:951-953
85. Remis RS, MacDonald KL, Riley LW, et al. Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med 1984;101:624-626
86. Roberts JA, Upton PA, Azene G. Escherichia coli O157:H7; an economic assessment of an outbreak. J Public Health Med 2000;22:99-107
87. Rowe PC, Walop W, Lior H, MacKenzie AM. Haemolytic anaemia after childhood Escherichia coli O157:H7 infection: Are females at increased risk? Epidemiolog Infect 1991;106: 523-530
88. Rowe PC, Orrbine E, Lior H, et al. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: Results of a canadian collaborative study. J Pediatr 1998;132:777-782
89. Rowe PC, Orrbine E, Ogborn M, et al. Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian Inuit community: Intestinal illness in family members as a risk factor. J Pediatr 1994;124:21-26
90. Salmon RL, Farrell ID, Hutchison JGP, Coleman DJ, Gross RJ, Fry NJ, Bowe B, Palmer SR. A christening party outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Eschericia coli O157:H7. Epidemiolog Infect 1989;103:249-254
91. Sanchez J, Dohoo IR, Christensen J, et al. Factors influencing the prevalence of Salmonella spp. in swine farms: A meta-Analysis approach. Prev Vet Med 2007;81:148-177
92. Shimazu T, Shimaoka M, Sugimoto H, et al. Does blood type B protect against haemolytic uraemic syndromé An analysis of the 1996 Sakai outbreak of Escherichia coli O157:H7 (VTEC O157) infection. J Infect 2000;41:45-49
93. Shiomi M, Togawa M, Fujita K, et al. Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7. Pediatr Int 1999;41:228-232
94. Takeda T. Strategy to prevent the progression of enterohemorrhagic Escherichia coli O157 infection to hemolytic uremic syndrome. Jpn J Med Sci Biol 1998;51:S124-S128
95. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-Analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007;26: 535-544
96. Townes JM, Deodhar AA, Laine ES, et al. Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: A population-based study. Ann Rheum Dis 2008;67:1689-1696
97. Tserenpuntsag B, Chang HG, Smith PF, et al. Hemolytic uremic syndrome risk and Escherichia coli O157:H7. Emerg Infec Dis 2005;11:1955-1957
98. Varma JK, Greene KD, Reller M, et al. An outbreak of Escherichia coli O157 infection following exposure to a contaminated building. JAMA 2003;290:2709-2712
99. Wall PG, McDonnell RJ, Adak GK, et al. General outbreaks of vero cytotoxin producing Escherichia coli O157 in England and Wales from 1992 to 1994. Commun Dis Rep CDR Rev 1996;6:R26-R33
100. Willshaw GA, Thirlwell J, Jones AP, et al. Vero cytotoxin-producing Escherichia coli O157 in beefburgers linked to an outbreak of diarrhoea, haemorrhagic colitis and haemolytic uraemic syndrome in Britain. Lett Appl Microbiol 1994;19: 304-307
101. Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolyticuremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000;342:1930-1936
102. Wood R, Donaghy M, Dundas S. Monitoring patients in the community with suspected Escherichia coli O157 infection during a large outbreak in Scotland in 1996. Epidemiol Infect 2001;127:413-420
103. World Health Organization. Global burden of disease 2004 update. Geneva, 2008
104. Yoshioka K, Yagi K, Moriguchi N. Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection: Experience of an outbreak in Sakai city, 1996. Pediatr Int 1999;41:223-227
105. Zoja C, Buelli S, Morigi M. Shiga toxin-Associated hemolytic uremic syndrome: Pathophysiology of endothelial dysfunction. Pediatr Nephrol 2010;25:2231-2240